MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
TGTX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

TG Therapeutics (TGTX) Earnings Date & Reports

TG Therapeutics Inc is a fully integrated, commercial-stage biotechnology company focused on the acquisition, development, and commercialization of novel treatments for B-cell diseases... Show more

Industry: #Biotechnology
A.I. Advisor
published Earnings

TGTX is expected to report earnings to rise 100.36% to 28 cents per share on May 11

TG Therapeutics TGTX Stock Earnings Reports
Q1'26
Est.
$0.28
Q4'25
Missed
by $0.23
Q3'25
Beat
by $2.21
Q2'25
Missed
by $0.02
Q1'25
Missed
by $0.13
The last earnings report on February 26 showed earnings per share of 14 cents, missing the estimate of 37 cents. With 2.08M shares outstanding, the current market capitalization sits at 5.79B.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
TGTX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. TGTX showed earnings on February 26, 2026. You can read more about the earnings report here.
View AI-Driven Trading for TGTX
A.I. Advisor
published General Information

General Information

a biopharmaceutical company

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
3020 Carrington Mill boulevard
Phone
+1 212 554-4484
Employees
264
Web
https://www.tgtherapeutics.com